Early intervention with effective therapeutics that treat hyperphagia in rare MC4R pathway diseases that lead to obesity may alleviate the symptoms that contribute to lower health-related quality of life and diminished school performance [27]. This evidence concerns the gene MC4R and obesity due to melanocortin 4 receptor deficiency.